Market Tracker

12/22 12:43pm ET

Galectin Therapeutics Inc (NASDAQ:GALT)

3.59
Real-Time Quote
 -0.05 / -1.37%
Today’s Change
3.45
Today|||52-Week Range
19.11
-55.57%
Year-to-Date
No recent news for Galectin Therapeutics Inc.

Today’s Trading

Previous close3.64
Today’s open3.63
Day’s range3.55 - 3.70
Volume70,088
Average volume (3 months)147,598
Market cap$80.5M
Dividend yield--
Data as of 12:28pm ET, 12/22/2014

Growth & Valuation

Earnings growth (last year)-80.56%
Earnings growth (this year)-8.45%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book74.87

Competitors

 Today’s
change
Today’s
% change
TROVTrovagene Inc-0.13-2.86%
CGIXCancer Genetics Inc-0.03-0.40%
PANGPanacea Global Inc0.000.00%
APPYVenaxis Inc-0.03-1.67%
Data as of 12:41pm ET, 12/22/2014

Financials

Next reporting dateMarch 13, 2015
EPS forecast (this quarter)-$0.17
Annual revenue (last year)$0.00
Annual profit (last year)-$21.1M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, CEO, Director &
Chief Medical Officer
Peter G. Traber
Chief Operating Officer &
Secretary
Harold H. Shlevin
Corporate headquarters
Norcross, Georgia

Forecasts